main results and the role of chance: A total of 1128 adnexal masses were resected, and 13 patients (1.5%) had ovarian malignancies: 6 ovarian cancer (1 mucinous, 1 endometrioid G1, 1 granulosa cell and 3 carcinoid) and 7 borderline tumors (BOTs; 5 mucinous and 2 serous). Of these, two patients with mucinous BOTs underwent fertility-sparing surgery and six patients underwent staging laparotomy. Due to cyst rupture during surgery, nine patients (69.2%) were upgraded to tumor stage IC. Secondary surgeries were performed in eight patients, with a mean interval of 88.9 days (range, 39 -182 days) between the surgeries. All patients were alive and without evidence of disease at follow-up (mean follow-up, 38 months; range, 6 -80 months).
Introduction
Laparoscopic surgery provides patients with a variety of benefits, including reduced post-surgical pain, faster recovery times, shorter hospital stays and superior cosmetic results when compared with open surgery. Recently, laparoscopic surgery has been increasingly used for malignant diseases. Although a few studies have reported that laparoscopic surgery might be a feasible means for the management of early-and advanced-stage malignant ovarian tumors (Liu et al., 2009; Nezhat et al., 2010; Park et al., 2013) , laparoscopic surgery is more commonly used for cervical and endometrial cancers. The use of laparoscopic surgery for the resection of ovarian tumors appears to be limited because laparoscopic surgery does not allow for full exploration of the abdominal cavity (to search for tumor implants) and because it is associated with the risk of an intraoperative rupture of ovarian cystic masses (Schorge et al., 2012) . In addition, port-site metastasis remains a major concern, even in cases of borderline ovarian tumors (BOTs) (Morice et al., 2004) .
In contrast, laparoscopic surgery has been widely recognized as the gold standard in the management of adnexal masses for which malignancy can be excluded preoperatively (Mayer et al., 2009; Seckin et al., 2011) . However, even when strict criteria are used to limit the use of laparoscopic surgery to those patients whose masses are most likely to be benign, some patients who undergo laparoscopic surgery are intraoperatively or post-operatively determined to have malignant tumors (Muzii et al., 2005) , a scenario known as unexpected ovarian malignancy. Intraoperative rupture of an unexpected ovarian malignancy is common, which results in upstaging from Stage IA to IC, further surgery, a need for adjuvant chemotherapy and a potential worsening of the patient's prognosis. Therefore, unexpected ovarian malignancy poses a dilemma for gynecologists.
In this study, we aimed to investigate the rate of unexpected ovarian malignancies among patients who underwent laparoscopic surgery for adnexal masses. In addition, we retrospectively studied the cases treated at our department to determine the clinicopathological features of unexpected ovarian malignancy.
Materials and Methods
From 1 May 2007 to 30 September 2013, a total of 1784 patients were laparoscopically treated at the Department of Obstetrics and Gynecology of Aichi Medical University Hospital, Nagakute, Japan. Our hospital is a teaching hospital and our practice is based primarily on medical referrals. There is no unit specialized in gynecologic oncology. After extensive screenings, including medical histories, physical examinations, assessments of tumor markers and imaging studies [ultrasonography, sometimes with the aid of magnetic resonance imaging (MRI) or computed tomography (CT)], all cases (excluding emergent cases) were presented at our department's weekly conference and the decision to perform laparoscopy was validated preoperatively.
Indications for surgical treatment of adnexal masses at our department include pain, a mass ≥6 cm, a mass present for ≥6 months and a mass suggestive of something other than a functional cyst. Only cases with ultrasonographic evidence of an adnexal cystic mass, without solid components (except for a pattern suggestive of a dermoid cyst), internal wall papillation, thick septa (≥3 mm) or evidence of ascites, were treated laparoscopically. In some cases, MRI or CT reports were also used as references. An elevated CA125 level without any of these radiological findings was not regarded as a contraindication for laparoscopy. Patients with adnexal masses suspected of malignancy underwent laparotomy with intraoperative frozen sectioning, and these patients were managed by gynecologic oncology specialists.
After general anesthesia was induced and pneumoperitoneum was established, a 10-mm laparoscope was placed through an infraumbilical incision. Under direct visual guidance, 10-and 5-mm ancillary ports were placed laterally to the epigastric arteries, in the right and left lower lateral quadrants, respectively. In some cases, the masses were found incidentally during surgery. Each patient underwent cystectomy or adnexectomy, depending on her age, clinical history and desire for future fertility. Ultimately, 884 of the 1784 patients underwent laparoscopic resection of their adnexal masses. We excluded cases where the procedure was converted to laparotomy before attempting resection of the masses due to severe pelvic adhesions. We retrospectively reviewed the final pathological reports of these 884 patients. Additionally, we reviewed the medical records of all patients who were diagnosed with ovarian malignancy and abstracted the demographic, clinical and pathologic information associated with these cases. All patients were staged according to the International Federation of Gynecology and Obstetrics staging system (1988) . Clinical outcomes at the end of March 2014 for each of the patients were evaluated. The Institutional Review Board of Aichi Medical University approved this study.
Results
The mean age of the 884 patients who underwent laparoscopic resection of their adnexal masses was 37.4 years (median, 36 years; range, 12-79 years). In 209 of these patients, the cysts were bilateral and/or multiple cysts were present in the same adnexa, thus the total yield was 1128 adnexal masses. The histologic diagnoses of the 1128 masses that were excised laparoscopically are summarized in Table I . The most frequent histological type resected by laparoscopy was an endometriotic cyst (38.0%), followed by a mature teratoma (30.9%). An intraoperative frozen section diagnosis was not routinely performed. Ad hoc, frozen sections from only nine patients were sent for pathological analyses based on intraoperative findings by the surgeons. All of these sections were diagnosed as benign, and the permanent sections were also diagnosed as benign. However, the final pathology indicated unexpected ovarian malignancies in 14 of the 1128 cysts (1.2%), corresponding to 13 of the 884 patients (1.5%).
Cases of unexpected ovarian malignancy
In six patients, the unexpected ovarian malignancy was an ovarian cancer (one mucinous, one endometrioid G1, one granulosa cell and three carcinoid) and in seven patients, the malignancy was a BOT (five mucinous and two serous). One patient had a bilateral mucinous BOT. All carcinoid tumors (two strumal and one trabecular) were malignant transformations that arose in ovarian mature cystic teratomas.
Details of the clinical and pathological characteristics of the ovarian cancer and BOT cases are presented in 
Excision and rupture of unexpected ovarian malignancies
Each of the 14 masses was removed by either cystectomy or adnexectomy.
In nine patients, the cysts were ruptured either intentionally to aspirate the cyst contents or unintentionally during adhesiolysis. Although none of the resected masses were assessed by frozen sections, each of the final pathology reports indicated ovarian malignancy. Secondary surgeries were performed in only 8 of the 13 patients (61.5%). There was a long delay before the second surgery, with a mean interval of 88.9 days (median, 77 days; range, 39-182 days), because it was difficult for the patients to reschedule another surgery after they had returned to normal daily activities. With regard to the secondary surgeries, two patients with mucinous BOT underwent fertility-sparing surgeries, whereas the other six patients underwent staging laparotomy. No malignant tissue was found in the specimens obtained during secondary surgery. The remaining five patients (38.5%) did not agree to undergo surgical staging. Except for one patient with Stage IB disease (Case 13), all patients presumably had Stage IA disease prior to laparoscopy. However, this was upstaged to Stage IC in nine patients (69.2%) as a result of spillage of the cyst contents during surgery. One patient with Stage IC mucinous adenocarcinoma (Case 11) received six cycles of chemotherapy, consisting of paclitaxel and carboplatin. All patients were alive and without evidence of disease at the last follow-up. The mean duration of follow-up was 38 months (median, 32 months; range, 7-80 months).
Discussion
Although operative laparoscopy has been recognized as the gold standard for the management of benign adnexal masses, the possibility of encountering an unexpected ovarian malignancy remains a major concern. Although the incidence of unexpected malignancy may vary depending on surgeons' individual strategies for managing laparoscopy, estimates of 11-19% have been previously reported when operative laparoscopies were widely used for the resection of adnexal masses that appeared sonographically complex (Canis et al., 1997; Biran et al., 2002; Muzii et al., 2005) . However, when laparoscopic surgeries are limited to patients with cysts that appear benign, the rate of unexpected malignancy is expected to be reduced to 0-2.5% (Canis et al., 1994; van Herendael et al., 1995; Muzii et al., 2005) , which is consistent with our findings (1.3% of cysts, 1.5% of patients).
In the case of an unexpected ovarian malignancy, cyst rupture is a particular concern because rupture may result in upstaging and changes to the subsequent treatment plan. Compared with laparotomy, (7) ATH, abdominal total hysterectomy; Bil, bilateral; BOT, borderline ovarian tumor; BSO, bilateral salpingo-oophorectomy; C/S, Cesarean section; LAVH, laparoscopically assisted vaginal hysterectomy; LSO, left salpingo-oophorectomy; Lt, left; N/ A, not applicable; ND, not done; NED, no evidence of disease; NEM, no evidence of malignancy; PAN, para-aortic lymphadenectomy; PLN, pelvic lymphadenectomy; pOM, partial omentectomy; RSO, right salpingo-oophorectomy; Rt., right; TLH, total laparoscopic hysterectomy.
a Co-existence of endometriosis.
Unexpected ovarian malignancy resected by laparoscopy laparoscopy is associated with an elevated incidence of cyst rupture during adnexal surgery (Iglesias and Ramirez, 2011) . In this study, nine patients (69.2%) were upstaged to Stage IC disease because cyst contents were spilled during surgery. Although the follow-up periods were relatively short, all patients were alive and without evidence of disease at the last follow-up. However, it is unclear whether tumor cell spillage influences patient prognosis, particularly in early-stage ovarian malignancy; indeed, the issue is still controversial (Dembo et al., 1990; Sainz de la Cuesta et al., 1994; Sjovall et al., 1994; Vergote et al., 2001; Havrilesky et al., 2003) . Although large prospective studies have not addressed this issue, a retrospective multicenter study by Vergote et al. (2001) found that the absence of intraoperative cyst rupture was an independent predictor of disease-free survival. In contrast, in a retrospective study of patients with early-stage ovarian cancer, Sjovall et al. (1994) found no difference in survival between patients with intact ovarian capsules and those with intraoperative capsule rupture. Recently, Kajiyama et al. (2014) reported that intraoperative spillage of the cyst contents did not affect the recurrence-free survival of patients in the setting of fertilitysparing surgery. Although this may partly endorse our findings, surgeons should avoid cyst rupture by all means.
Improper and delayed surgical staging may also adversely affect the patient's prognosis, and therefore are major concerns in the management of ovarian malignancy. Our case series is unique in that the malignancies went unrecognized until the final pathology report. Such cases have been termed 'totally unexpected ovarian malignancy' (Muzii et al., 2005) , and any adverse effects caused by delayed staging are believed to be exacerbated in such cases. A multicenter retrospective study by Lehner (1998) demonstrated that delays in laparotomy after the laparoscopic excision of unrecognized ovarian malignancies had a negative impact on the distribution of disease stage. In particular, patients whose laparotomies were delayed for .17 days were substantially more likely to have advanced tumors when compared with patients who underwent laparotomy immediately or within 17 days of laparoscopy. In contrast, we were unable to detect any advanced tumors in the eight patients who underwent secondary surgeries, even though there was a long delay before the second surgery, with an average intersurgery interval of 88.9 days. Although we cannot explain why our findings were not concordant with the results reported by Lehner et al. (1998) , it is worth mentioning that our study involved only a single institute and that the patients may have been subject to more stringent selection criteria for laparoscopic surgery.
Our results suggest that preoperative screening for malignancy might be an important means of minimizing the risk of unexpected ovarian malignancy. However, it is widely recognized that ovarian malignancy is difficult to detect during its early stages. Indeed, we failed to detect early-stage disease in 13 patients, in whom the microscopic features of malignancy were limited to minimal portions of the cysts. The serum CA125 levels were not helpful and were elevated in only two premenopausal women with endometriosis. Although CA125 is the most frequently used serum marker for identifying ovarian malignancy, elevated CA125 levels can be observed in patients with other cancers, benign gynecologic conditions and even non-gynecologic conditions (Kobayashi et al., 2012) . Nossov et al. (2008) found that serum CA125 had positive and negative predictive values of 57 and 70.6% for the early detection of ovarian cancer, respectively. In addition, a recent randomized control trial demonstrated that the positive predictive value of CA125 testing was slightly .1% across all of the screening rounds even when combined with transvaginal ultrasonography screening (Partridge et al., 2009) . In the setting of laparoscopy, Nezhat et al. (1992) reported that CA125 levels, pelvic ultrasound and peritoneal cytologic testing were each unable to exclude malignancy because of insufficient diagnostic sensitivity.
To increase the accuracy of the detection of ovarian malignancies, several malignancy risk algorithms have been proposed to date. The Royal College of Obstetricians and Gynaecologists (RCOG Guideline, Green Top 34, 2010) recommends the use of the risk of malignancy index (RMI) (Jacobs et al., 1990) as a diagnostic tool for ovarian malignancy in post-menopausal women. However, the RMI depends heavily on the serum CA125 level, which limits its utility in BOTs and early-stage ovarian cancer (Kaijser et al., 2014) . Indeed, retrospective re-evaluation with the RMI system revealed that none of our cases had scores exceeding the cut-off point of 250. A recent systematic and meta-analysis by Kaijser et al. (2014) showed that IOTA LR2 (Van Holsbeke et al., 2009) and Simple Rules (Timmerman et al., 2008) are currently the best diagnostic algorithms for differentiating between benign and malignant adnexal masses in a preoperative setting. The addition of an intraoperative frozen section diagnosis may also reduce the risk of unexpected ovarian malignancy (Bensaid et al., 2006; Cross et al., 2012) . Bensaid et al. (2006) reported that the addition of frozen section diagnosis improved the diagnostic performance of laparoscopy, yielding a sensitivity and specificity of 100 and 100%, respectively. In contrast, we applied ad hoc, frozen section diagnosis for only nine doubtful cases, which were found to be benign both intra-and post-operatively. Although it is unknown why our results were not consistent with those found by Bensaid et al. (2006) , we speculate that this occurred because we applied laparoscopy for resection of only presumably benign adnexal masses.
As a result, we failed to preoperatively diagnose ovarian malignancy in 13 patients (1.5%). Again, there was a long delay before the second surgery, with a mean interval of 88.9 days, and almost 40% of the patients did not undergo surgical staging. Nevertheless, the prognosis of the patients was not altered in the context of relatively short follow-up periods. The reasons for this excellent prognosis remain unknown. This result may be explained by the assumption that all patients, except for one Stage IB patient, had Stage IA disease prior to surgery, although nine patients were upstaged to Stage IC due to surgical rupture. In addition, the present series included seven BOTs and four G2 ovarian cancer patients. The prognosis of such patients is considered to be favorable, and conservative surgeries may be proposed to patients who hope to preserve their fertility (Morice et al., 2003; Tinelli et al., 2006; Darai et al., 2013) . Otherwise, totally unexpected ovarian malignancies may represent a substantially different form of disease than the more overt carcinomas that are treated with primary laparotomy (Muzii et al., 2005; Deligdisch et al., 2007) .
In conclusion, this study revealed that unexpected ovarian malignancy was rare among patients who were carefully selected for the laparoscopic resection of adnexal masses. The presence of an early-stage unexpected ovarian malignancy did not alter the prognosis of the patients, even if there was a significant delay in surgical staging after an unexpected malignancy was found following laparoscopy.
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